← Back to Clinical Trials
Recruiting NCT05675618

NCT05675618 Return to Golf After Orthopaedic Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05675618
Status Recruiting
Phase
Sponsor Hospital for Special Surgery, New York
Condition Hip Osteoarthritis
Study Type OBSERVATIONAL
Enrollment 432 participants
Start Date 2023-01-09
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 432 participants in total. It began in 2023-01-09 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The GOLF study is a multicenter, prospective study with the goal to investigate golfers' return to the sport following hip, knee or shoulder arthroplasty. The prevalence of return to golf, by level of returning to golf will be assessed at 6 weeks, 3 months, 6 months, and 12 months postoperatively. Patients who are active golfers undergoing joint replacement will be identified from outpatient clinics and pre-assessment clinics and given information about the study at least two weeks prior to surgery. Participants in this study must have a desire to return to golf after surgery. Previous studies have only been able to report the return to golf after arthroplasty retrospectively; the prospective nature of this study will allow for a greater understanding of this process.

Eligibility Criteria

Inclusion Criteria: * Age 18+ years * A self-reported golfer * Able to consent to treatment * Indicated for one of the following surgical procedures: total hip arthroplasty, hip resurfacing, revision hip arthroplasty, total knee arthroplasty, unicompartmental knee arthroplasty, revision knee arthroplasty, total shoulder arthroplasty, reverse shoulder arthroplasty, shoulder resurfacing arthroplasty, revision shoulder arthroplasty Exclusion Criteria: * Inability to complete follow-up questionnaires * Declining operative management * No desire to return to golf postoperatively * Medical problem that affects the patient's ability to play golf (e.g., angina, shortness of breath, etc.)

Contact & Investigator

Central Contact

Andrew Creighton, DO

✉ creightona@hss.edu

📞 646-344-4340

Frequently Asked Questions

Who can join the NCT05675618 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Hip Osteoarthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05675618 currently recruiting?

Yes, NCT05675618 is actively recruiting participants. Contact the research team at creightona@hss.edu for enrollment information.

Where is the NCT05675618 trial being conducted?

This trial is being conducted at New York, United States, Edinburgh, United Kingdom.

Who is sponsoring the NCT05675618 clinical trial?

NCT05675618 is sponsored by Hospital for Special Surgery, New York. The trial plans to enroll 432 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology